John Shulman

Verified

Managing Member at Juggernaut ManagementListed on SEC Form ADVWashington, United States

Claim this profile

Cold

Check Size

Not yet known

Reliability Score

🎯100% of deals in Healthcare

Investment Timeline

Metuchen Pharmaceuticals

Board seat (SEC Form D)Source

Since Jan 2020

Company last raised Jan 2020

Portfolio Breakdown

By Sector

Healthcare1 deal · 100%

By Stage

1 tracked deal1 sector · 0 stages

Deal Velocity

Avg Deals / Year

1.0

Avg Deal Size

Unknown

Largest Deal

Metuchen Pharmaceuticals

Unknown

YoY Trend

Steady

Deals Per Year

1 total deal tracked2020–2020

Investment Activity Map

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

2020

Less

Current Fund Status

Fund Name

Juggernaut Capital Partners II, L.P.

Reported Size

$67.9M

Co-Investors

No co-investment data available yet.